Παρακολούθηση
Buelent Polat
Buelent Polat
University Hospital Wuerzburg, Department of Radiation Oncology
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα ukw.de
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving …
V Strnad, OJ Ott, G Hildebrandt, D Kauer-Dorner, H Knauerhase, T Major, ...
The Lancet 387 (10015), 229-238, 2016
728*2016
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving …
V Strnad, OJ Ott, G Hildebrandt, D Kauer-Dorner, H Knauerhase, T Major, ...
The Lancet 387 (10015), 229-238, 2016
6892016
Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12
E Fokas, M Allgäuer, B Polat, G Klautke, GG Grabenbauer, R Fietkau, ...
Journal of Clinical Oncology 37 (34), 3212-3222, 2019
4022019
Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma
M Fassnacht, S Hahner, B Polat, AC Koschker, W Kenn, M Flentje, ...
The Journal of Clinical Endocrinology & Metabolism 91 (11), 4501-4504, 2006
2982006
Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery …
C Polgár, OJ Ott, G Hildebrandt, D Kauer-Dorner, H Knauerhase, T Major, ...
The Lancet Oncology 18 (2), 259-268, 2017
2682017
Radiotherapy in adrenocortical carcinoma
B Polat, M Fassnacht, L Pfreundner, M Guckenberger, K Bratengeier, ...
Cancer 115 (13), 2816-2823, 2009
2152009
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
C Bluemel, M Krebs, B Polat, F Linke, M Eiber, S Samnick, C Lapa, ...
Clinical nuclear medicine 41 (7), 515-521, 2016
2122016
Dose–response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy
M Guckenberger, K Baier, B Polat, A Richter, T Krieger, J Wilbert, ...
Radiotherapy and Oncology 97 (1), 65-70, 2010
1772010
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO …
E Fokas, A Schlenska-Lange, B Polat, G Klautke, GG Grabenbauer, ...
JAMA oncology 8 (1), e215445-e215445, 2022
1592022
Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast …
R Schäfer, V Strnad, C Polgár, W Uter, G Hildebrandt, OJ Ott, ...
The lancet oncology 19 (6), 834-844, 2018
1122018
GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early …
OJ Ott, V Strnad, G Hildebrandt, D Kauer-Dorner, H Knauerhase, T Major, ...
Radiotherapy and oncology 120 (1), 119-123, 2016
1052016
Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer
M Guckenberger, S Ok, B Polat, RA Sweeney, M Flentje
Strahlentherapie und Onkologie 10 (186), 535-543, 2010
1042010
A multi-institution evaluation of deformable image registration algorithms for automatic organ delineation in adaptive head and neck radiotherapy
N Hardcastle, WA Tomé, DM Cannon, CL Brouwer, PWH Wittendorp, ...
Radiation oncology 7, 1-7, 2012
942012
Nonrigid patient setup errors in the head-and-neck region.
B Polat, J Wilbert, K Baier, M Flentje, M Guckenberger
Strahlentherapie und Onkologie 183 (9), 2007
942007
Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer
B Polat, I Guenther, J Wilbert, J Goebel, RA Sweeney, M Flentje, ...
Strahlentherapie und Onkologie 184 (12), 668, 2008
902008
Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci
CS Djuzenova, I Elsner, A Katzer, E Worschech, LV Distel, M Flentje, ...
Radiation oncology 8, 1-12, 2013
882013
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings
HD Hummel, P Kufer, C Grüllich, R Seggewiss-Bernhardt, ...
Immunotherapy 13 (2), 125-141, 2021
822021
Dose-intensified versus conventional-dose salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: the SAKK 09/10 randomized phase 3 trial
P Ghadjar, S Hayoz, J Bernhard, DR Zwahlen, T Hölscher, P Gut, B Polat, ...
European urology 80 (3), 306-315, 2021
812021
Radiosensitization of glioblastoma cell lines by the dual PI3K and mTOR inhibitor NVP-BEZ235 depends on drug-irradiation schedule
S Kuger, D Graus, R Brendtke, N Günther, A Katzer, P Lutyj, B Polat, ...
Translational oncology 6 (2), 169-IN16, 2013
702013
Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells
C Shen, A Buck, B Polat, A Schmid-Kotsas, C Matuschek, HJ Gross, ...
Cancer gene therapy 10 (5), 403-410, 2003
702003
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20